Literature DB >> 34704419

Screening for neonatal inherited metabolic disorders by tandem mass spectrometry in Guangzhou.

Chengfang Tang1, Minyi Tan1, Ting Xie1, Fang Tang1, Sichi Liu1, Qingxiu Wei1, Jilian Liu1, Yonglan Huang1.   

Abstract

To analyze the screening results for inherited metabolic disorders (IMD) in newborns by tandem mass spectrometry (MS/MS) in Guangzhou.A total of 272 117 newborns in Guangzhou from Jan 2015 to Dec 2020 were screened for IMD by MS/MS in Guangzhou Newborn Screening Center. When the primary screening was positive, the newborns and their mothers were recalled. For those with positive in re-examination, the biochemical and related genetic analysis were required for confirmation. The screening results, clinical characteristics and outcomes of the confirmed cases were retrospectively analyzed and the performance was optimized. Among 272 117 neonates, 1808 (0.66%) cases were positive in primary screening, and 1738 cases (96.13%) were recalled for review. The median clinical diagnosis time was 15 d after birth. A total of 79 cases of IMD were diagnosed, including 23 with aminoacidopathy, 17 with disorder of organic acid metabolism and 39 with fatty acid oxidation disorders, involving 21 diseases. The incidence rate was 1/3444 in newborns, and the positive predictive value of 4.5%. Four false negative cases were found, all of them were citrin deficiency. The common diseases were primary carnitine deficiency (26.6%), methylmalonic aciduria (12.7%) and phenylalanine hydroxylase deficiency (11.4%). The mothers of 32 cases were confirmed, including 30 cases of primary carnitine deficiency, 1 case of isobutyl-coenzyme A dehydrogenase deficiency and 1 case of 3-methylcromaryl coenzyme A carboxylase deficiency. The detection rate was 1/2451 in total population. During the follow-up, most patients remain asymptomatic, except for 5 severe cases who died early (1 case of maple syrup urine disease, 2 cases of isolated methylmalonic acidurmia, and 2 cases of carnitine-acylcarnitine translocase deficiency); and 10 cases of organic acid metabolism disorders developed mild psychomotor developmental retardation. After optimizing the screening indicators, the number of initial screening positives dropped to 903, and the positive predictive value increased to 9.1%, and no confirmed cases were missed. The incidence rate of fatty acid oxidation disorders is high in Guangzhou. A variety of IMD can be effectively screened out by MS/MS, and the screening performance can be improved by optimizing screening indicators.

Entities:  

Keywords:  Aminoacidopathy; Citrin deficiency; Disorder of organic acid metabolism; Fatty acid oxidation disorders; Metabolism, inborn errors; Neonatal screening; Tandem mass spectrometry

Mesh:

Year:  2021        PMID: 34704419      PMCID: PMC8714483          DOI: 10.3724/zdxbyxb-2021-0260

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  21 in total

Review 1.  Expanded newborn screening by mass spectrometry: New tests, future perspectives.

Authors:  Daniela Ombrone; Elisa Giocaliere; Giulia Forni; Sabrina Malvagia; Giancarlo la Marca
Journal:  Mass Spectrom Rev       Date:  2015-05-07       Impact factor: 10.946

2.  [Expert consensus on the follow-up of newborn screening for neonatal genetic and metabolic diseases].

Authors:  Mingcai Ou; Jianhui Jiang; Zhiguo Wang
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2020-04-10

3.  [The phenotypes and genotypes in 314 patients with isolated methylmalonic acidemia].

Authors:  L L Kang; Y P Liu; M Shen; Z H Chen; J Q Song; R X He; Y Liu; Y Zhang; H Dong; M Q Li; Y Jin; H Zheng; Q Wang; Y Ding; X Y Li; D X Li; H X Li; X Q Liu; H J Xiao; Y W Jiang; H Xiong; C Y Zhang; Z X Wang; Y Yuan; D S Liang; Y P Tian; Y L Yang
Journal:  Zhonghua Er Ke Za Zhi       Date:  2020-06-02

4.  [Newborn screening program and blood amino acid profiling in early neonates with citrin deficiency].

Authors:  C F Tang; S C Liu; Y Feng; H F Mei; H P Liu; J W Feng; L X Ye; G Q Wang; L Liu; Y L Huang
Journal:  Zhonghua Er Ke Za Zhi       Date:  2019-10-02

5.  [Screening for neonatal inborn errors of metabolism by electrospray ionization-tandem mass spectrometry and follow-up].

Authors:  Xin-wen Huang; Jian-bin Yang; Fan Tong; Ru-lai Yang; Hua-qing Mao; Xue-lian Zhou; Xiao-lei Huang; Li-li Yang; Cheng-gang Huang; Zheng-yan Zhao
Journal:  Zhonghua Er Ke Za Zhi       Date:  2011-10

6.  Expanded newborn screening in New South Wales: missed cases.

Authors:  Jane Estrella; Bridget Wilcken; Kevin Carpenter; Kaustuv Bhattacharya; Michel Tchan; Veronica Wiley
Journal:  J Inherit Metab Dis       Date:  2014-06-27       Impact factor: 4.982

7.  [Screening for amino acid metabolic disorders of newborns in Zhejiang province:prevalence, outcome and follow-up].

Authors:  Xinwen Huang; Yu Zhang; Fang Hong; Jing Zheng; Jianbin Yang; Fan Tong; Huaqing Mao; Xiaolei Huang; Xuelian Zhou; Rulai Yang; Zhengyan Zhao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2017-05-25

8.  Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.

Authors:  Martin Lindner; Gwendolyn Gramer; Gisela Haege; Junmin Fang-Hoffmann; Karl O Schwab; Uta Tacke; Friedrich K Trefz; Eugen Mengel; Udo Wendel; Michael Leichsenring; Peter Burgard; Georg F Hoffmann
Journal:  Orphanet J Rare Dis       Date:  2011-06-20       Impact factor: 4.123

9.  Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population.

Authors:  Ting Wang; Jun Ma; Qin Zhang; Ang Gao; Qi Wang; Hong Li; Jingjing Xiang; Benjing Wang
Journal:  Front Genet       Date:  2019-10-29       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.